These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15501766)
1. Glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, inhibits the progression of group B streptococcal arthritis. Tissi L; Puliti M; Bistoni F; Mosci P; Kozel TR; Vecchiarelli A Infect Immun; 2004 Nov; 72(11):6367-72. PubMed ID: 15501766 [TBL] [Abstract][Full Text] [Related]
2. Role of interleukin-18 in experimental group B streptococcal arthritis. Tissi L; McRae B; Ghayur T; von Hunolstein C; Orefici G; Bistoni F; Puliti M Arthritis Rheum; 2004 Jun; 50(6):2005-13. PubMed ID: 15188378 [TBL] [Abstract][Full Text] [Related]
3. The beneficial effect of interleukin-12 on arthritis induced by group B streptococci is mediated by interferon-gamma and interleukin-10 production. Puliti M; von Hunolstein C; Bistoni F; Mosci P; Orefici G; Tissi L Arthritis Rheum; 2002 Mar; 46(3):806-17. PubMed ID: 11920419 [TBL] [Abstract][Full Text] [Related]
4. Regulatory role of interleukin-10 in experimental group B streptococcal arthritis. Puliti M; Von Hunolstein C; Verwaerde C; Bistoni F; Orefici G; Tissi L Infect Immun; 2002 Jun; 70(6):2862-8. PubMed ID: 12010973 [TBL] [Abstract][Full Text] [Related]
5. IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B Streptococcus infection. Tissi L; Bistoni F; Puliti M Mediators Inflamm; 2009; 2009():394021. PubMed ID: 19606256 [TBL] [Abstract][Full Text] [Related]
6. Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. Puliti M; Momi S; Falcinelli E; Gresele P; Bistoni F; Tissi L Arthritis Rheum; 2012 Apr; 64(4):1089-97. PubMed ID: 22042442 [TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor alpha, interleukin-1beta, and interleukin-6 in a mouse model of group B streptococcal arthritis. Tissi L; Puliti M; Barluzzi R; Orefici G; von Hunolstein C; Bistoni F Infect Immun; 1999 Sep; 67(9):4545-50. PubMed ID: 10456898 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease. Puliti M; Uematsu S; Akira S; Bistoni F; Tissi L Infect Immun; 2009 Apr; 77(4):1524-31. PubMed ID: 19179417 [TBL] [Abstract][Full Text] [Related]
9. A microbial polysaccharide reduces the severity of rheumatoid arthritis by influencing Th17 differentiation and proinflammatory cytokines production. Monari C; Bevilacqua S; Piccioni M; Pericolini E; Perito S; Calvitti M; Bistoni F; Kozel TR; Vecchiarelli A J Immunol; 2009 Jul; 183(1):191-200. PubMed ID: 19542430 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthase exacerbates group B streptococcus sepsis and arthritis in mice. Puliti M; von Hunolstein C; Bistoni F; Orefici G; Tissi L Infect Immun; 2004 Aug; 72(8):4891-4. PubMed ID: 15271956 [TBL] [Abstract][Full Text] [Related]
12. Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties. Ramos CL; Fonseca FL; Rodrigues J; GuimarĂ£es AJ; Cinelli LP; Miranda K; Nimrichter L; Casadevall A; Travassos LR; Rodrigues ML Eukaryot Cell; 2012 Sep; 11(9):1086-94. PubMed ID: 22562469 [TBL] [Abstract][Full Text] [Related]
13. Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1. De Jesus M; Park CG; Su Y; Goldman DL; Steinman RM; Casadevall A Med Mycol; 2008 Mar; 46(2):153-62. PubMed ID: 18324494 [TBL] [Abstract][Full Text] [Related]
14. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages. Grinsell M; Weinhold LC; Cutler JE; Han Y; Kozel TR J Infect Dis; 2001 Aug; 184(4):479-87. PubMed ID: 11471106 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan. Chiapello LS; Baronetti JL; Aoki MP; Gea S; Rubinstein H; Masih DT Immunology; 2004 Nov; 113(3):392-400. PubMed ID: 15500627 [TBL] [Abstract][Full Text] [Related]
16. Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages. Chang ZL; Netski D; Thorkildson P; Kozel TR Infect Immun; 2006 Jan; 74(1):144-51. PubMed ID: 16368967 [TBL] [Abstract][Full Text] [Related]
17. Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations. Nimrichter L; Frases S; Cinelli LP; Viana NB; Nakouzi A; Travassos LR; Casadevall A; Rodrigues ML Eukaryot Cell; 2007 Aug; 6(8):1400-10. PubMed ID: 17573547 [TBL] [Abstract][Full Text] [Related]
18. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis. Tissi L; von Hunolstein C; Bistoni F; Marangi M; Parisi L; Orefici G J Med Microbiol; 1998 Aug; 47(8):717-23. PubMed ID: 9877193 [TBL] [Abstract][Full Text] [Related]
19. Influence of interferon-gamma administration on the severity of experimental group B streptococcal arthritis. Puliti M; von Hunolstein C; Bistoni F; Mosci P; Orefici G; Tissi L Arthritis Rheum; 2000 Dec; 43(12):2678-86. PubMed ID: 11145025 [TBL] [Abstract][Full Text] [Related]
20. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Monari C; Retini C; Casadevall A; Netski D; Bistoni F; Kozel TR; Vecchiarelli A Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]